ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 129 filers reported holding ARATANA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $7,306,000 | +43.2% | 1,415,824 | -0.1% | 0.69% | +36.8% |
| Q1 2019 | $5,101,000 | -48.0% | 1,416,926 | -11.4% | 0.51% | -50.9% |
| Q4 2018 | $9,804,000 | -10.4% | 1,599,365 | -14.7% | 1.03% | +9.5% |
| Q3 2018 | $10,946,000 | +59.2% | 1,874,364 | +15.9% | 0.94% | +50.3% |
| Q2 2018 | $6,876,000 | -3.6% | 1,617,923 | 0.0% | 0.63% | -7.5% |
| Q1 2018 | $7,135,000 | +21.3% | 1,617,923 | +44.7% | 0.68% | +18.6% |
| Q4 2017 | $5,880,000 | +10.6% | 1,117,923 | +28.9% | 0.57% | +13.1% |
| Q3 2017 | $5,318,000 | +18.9% | 867,600 | +40.2% | 0.50% | +11.5% |
| Q2 2017 | $4,473,000 | +60.9% | 618,660 | +18.0% | 0.45% | +66.5% |
| Q1 2017 | $2,780,000 | -20.3% | 524,459 | +8.0% | 0.27% | -22.7% |
| Q4 2016 | $3,486,000 | -9.6% | 485,468 | +17.8% | 0.35% | -10.7% |
| Q3 2016 | $3,857,000 | +48.1% | 412,101 | 0.0% | 0.39% | +45.4% |
| Q2 2016 | $2,604,000 | – | 412,101 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 3,487,149 | $21,376,000 | 3.96% |
| Broadfin Capital, LLC | 4,083,135 | $25,030,000 | 3.29% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $1,533,000 | 1.30% |
| GENERAL AMERICAN INVESTORS CO INC | 1,599,365 | $9,804,000 | 1.03% |
| Grandeur Peak Global Advisors, LLC | 821,038 | $5,033,000 | 0.65% |
| CADENCE CAPITAL MANAGEMENT LLC | 307,294 | $1,884,000 | 0.19% |
| Redmond Asset Management, LLC | 60,176 | $369,000 | 0.18% |
| Alambic Investment Management, L.P. | 65,000 | $398,000 | 0.17% |
| MENTA CAPITAL LLC | 39,562 | $243,000 | 0.09% |
| Campbell & CO Investment Adviser LLC | 12,990 | $88,000 | 0.09% |